UK Plans Landmark Study on Puberty-Blockers’ Effect on Children With Gender Distress: Critics Express Doubt It Will Advance the Weak Evidence Base
The stakes of this hotly anticipated trial have only heightened since President Trump’s second term has posed an existential threat to such research in the United States.
The United Kingdom will spend $13.9 million to study the impacts of puberty blockers on minors experiencing gender-related distress. The U.K.’s National Health Service earlier this month announced its plan to invest in much-anticipated research into the controversial treatments, for which there remains insufficient data, per an NHS-commissioned report called the Cass Review. The study still needs to pass muster with an NHS ethics board.
Please check your email.
A verification code has been sent to
Didn't get a code? Click to resend.
To continue reading, please select:
Enter your email to read for FREE
Get 1 FREE article
Join the Sun for a PENNY A DAY
$0.01/day for 60 days
Cancel anytime
100% ad free experience
Unlimited article and commenting access
Full annual dues ($120) billed after 60 days
